Oncolytics is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated encourag ...

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients suffering from chronic and acute retinal diseases, including dry AMD/G ...

Optieum Biotechnologies is developing an innovative cancer immunotherapy utilizing our proprietary Eumbody System™ to discover and engineer CAR-T cells for the treatment of solid tumors, autoimmune di ...

Orrick is a global law firm with offices in 25+ markets worldwide, focused on serving the life sciences & healthtech, technology & innovation, energy & infrastructure, and finance sectors. We provide ...

Oxymo Technologies. https://www.oxymotech.com/ , is a Canadian biotechnology company focused on the development of drugs for the treatment of Herpes Simplex Virus (HSV1/HSV2) infection. Herpes simplex ...

Otsuka Holdings Co., Ltd. is a Japan-based pharmaceutical holding company engaged in four business segments.

Oncode Accelerator is a unique cancer research network in the Netherlands which aims to innovate and accelerate the development of new cancer therapies. At BIO, we're looking for interesting new thera ...

Oncolys BioPharma is a public clinical-stage company developing oncolytic viruses . OBP-301 is the first-in-class oncolytic adenovirus for Esophageal Cancer. In a pivotal Phase II study conducted in J ...

We provide capital and support to spinouts that are commercializing the most exciting and groundbreaking scientific innovations emerging from the world’s greatest research institutions.